Literature DB >> 12814761

Antinuclear antibodies recognize cellular autoantigens driven by apoptosis.

Roxana Ramírez-Sandoval1, Sergio H Sánchez-Rodríguez, David Herrera-van Oostdam, Esperanza Avalos-Díaz, Rafael Herrera-Esparza.   

Abstract

OBJECTIVE: Present study addresses the issue whether cellular antigens recognised by antinuclear autoantibodies are driven by apoptosis.
MATERIALS AND METHODS: HEp-2 cells were committed to apoptosis by camptothecin; DNA fragmentation and FasL and Bax expression monitored apoptosis. Autoantigens were probed by indirect immunofluorescence and Western blot with autoantibodies or monoclonals against: DNA, Ro60, La, U1-RNP, CENP-B, DNA Topoisomerase I, Jo-1 and NuMA. A comparison of antinuclear antibody reactivity between living and apoptotic cells was performed by ELISA.
RESULTS: Apoptotic changes such as chromatin fragmentation, blebs and apoptotic bodies were induced with 20 mM camptothecin. Autoantigens were better detected in apoptotic cells. U1-RNP, Jo1, DNA-Topoisomerase I, CENP-B and NuMA exhibited fragmentation and redistribution as a consequence of apoptosis; in contrast, Ro60 and La ribonucleoproteins did not show proteolysis. Additionally the ELISA titers of antinuclear antibodies were higher in apoptotic cells than in normal cells.
CONCLUSION: Apoptosis induces molecular changes in different autoantigens, this modification increases the antigen-driven response of autoantibodies such as anti-RNP, anti-DNA Topoisomerase I, anti-CENP-B and anti-Jo1. Apoptotic changes would contribute to break down the tolerance in autoimmune connective tissue disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12814761     DOI: 10.1016/s1297-319x(03)00019-8

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  9 in total

1.  Autoantibodies to mitotic apparatus: association with other autoantibodies and their clinical significance.

Authors:  Branka Bonaci-Nikolic; Sladjana Andrejevic; Mirjana Bukilica; Ivana Urosevic; Milos Nikolic
Journal:  J Clin Immunol       Date:  2006-08-29       Impact factor: 8.317

Review 2.  Myositis-specific autoantibodies: detection and clinical associations.

Authors:  Sander H J van Dooren; Walther J van Venrooij; Ger J M Pruijn
Journal:  Auto Immun Highlights       Date:  2011-03-23

3.  Nuclear-targeting autoantibodies induced nuclear PARP cleavage accompanied by more pronounced decrease of peripheral white blood cells than Ro/SSA and La/SSB antigen-targeting autoantibodies.

Authors:  Ingrid Böhm
Journal:  J Clin Immunol       Date:  2005-03       Impact factor: 8.317

4.  Human parvovirus B19 nonstructural protein NS1 enhanced the expression of cleavage of 70 kDa U1-snRNP autoantigen.

Authors:  Bor-Show Tzang; Der-Yuan Chen; Chun-Chou Tsai; Szu-Yi Chiang; Tsung-Ming Lin; Tsai-Ching Hsu
Journal:  J Biomed Sci       Date:  2010-05-25       Impact factor: 8.410

5.  Anti-nuclear antibodies in patients with breast cancer.

Authors:  R Nisihara; M C C Machoski; A Neppel; C A Maestri; I Messias-Reason; T L Skare
Journal:  Clin Exp Immunol       Date:  2018-06-14       Impact factor: 4.330

6.  Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis.

Authors:  Christopher W Pohlmeyer; Ching Shang; Pei Han; Zhi-Hua Cui; Randall M Jones; Astrid S Clarke; Bernard P Murray; David A Lopez; David W Newstrom; M David Inzunza; Franziska G Matzkies; Kevin S Currie; Julie A Di Paolo
Journal:  BMC Rheumatol       Date:  2021-03-30

7.  Increased Autoantibodies Against Ro/SS-A, CENP-B, and La/SS-B in Patients With Kidney Allograft Antibody-mediated Rejection.

Authors:  Sergi Clotet-Freixas; Max Kotlyar; Caitriona M McEvoy; Chiara Pastrello; Sonia Rodríguez-Ramírez; Sofia Farkona; Heloise Cardinal; Mélanie Dieudé; Marie-Josée Hébert; Yanhong Li; Olusegun Famure; Peixuen Chen; S Joseph Kim; Emilie Chan; Igor Jurisica; Rohan John; Andrzej Chruscinski; Ana Konvalinka
Journal:  Transplant Direct       Date:  2021-09-20

8.  A retrospective study on IVF/ICSI outcome in patients with anti-nuclear antibodies: the effects of prednisone plus low-dose aspirin adjuvant treatment.

Authors:  Qing Zhu; Li Wu; Bo Xu; Mei-Hong Hu; Xian-Hong Tong; Jing-Juan Ji; Yu-Sheng Liu
Journal:  Reprod Biol Endocrinol       Date:  2013-10-05       Impact factor: 5.211

9.  Novel functional small RNAs are selectively loaded onto mammalian Ago1.

Authors:  Natsuko Yamakawa; Kazuki Okuyama; Jun Ogata; Akinori Kanai; Aleksandra Helwak; Masako Takamatsu; Ken-ichi Imadome; Kohei Takakura; Bidisha Chanda; Natsumi Kurosaki; Haruna Yamamoto; Kiyoshi Ando; Hirotaka Matsui; Toshiya Inaba; Ai Kotani
Journal:  Nucleic Acids Res       Date:  2014-03-13       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.